Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer
Go back to Kymera Therapeutics Appoints Noah Goodman as Chief Business Officer| (NASDAQ: KYMR) | Delayed: 122.05 -3.5 (2.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.55 | 52 Week High | $ | |||
| Open | $124.99 | 52 Week Low | $ | |||
| Day High | $125.07 | P/E | N/A | |||
| Day Low | $121.46 | EPS | $ | |||
| Volume | 297,409 | |||||

